Results 271 to 280 of about 626,622 (390)

Hormone replacement therapy was associated with increased venous thromboembolism and deep venous thrombosis [PDF]

, 2000
David Atkins, Jill Miller
openalex   +1 more source

Measuring and Managing Obesity in Pregnancy Using the Edmonton Obesity Staging System: A Scoping Review

Clinical Obesity, EarlyView.
ABSTRACT Emerging evidence and clinical practice guidelines have highlighted that obesity, defined as a chronic disease characterised by excess or dysfunctional adipose tissue, may not be accurately measured or understood by solely relying on body mass index (BMI) which is a measure of size not functionality.
Taniya S. Nagpal, Jordyn M. Cox, Ximena Ramos Salas, Kristi B. Adamo   +3 more
wiley   +1 more source

Complex Venous Thromboembolism in a Young Woman With Multisystem Manifestations: A Case Report. [PDF]

Cureus
Alswij MA, Marina S, Musleh M, Alokla D, Alhaj Hasan A.   +4 more
europepmc   +1 more source

The recurrence rate of venous thromboembolism after a first or second episode of deep venous thrombosis was high [PDF]

, 2000
Rebecca J. Beyth
openalex   +1 more source

Beyond BMI: Practical Guide for Clinicians to Integrate the Lancet Commission's Obesity Framework and King's Obesity Staging System

Clinical Obesity, EarlyView.
ABSTRACT Body mass index (BMI) on its own is a poor diagnostic and staging tool for obesity because it does not measure health status. The newly published Lancet Clinical Obesity Criteria (LCOC) for defining clinical obesity distinguish preclinical and clinical obesity based on organ or tissue dysfunction.
Tak Ying Louise Ko, Alexander D. Miras, Dimitri J. Pournaras, Carel W. Le Roux   +3 more
wiley   +1 more source

From Algorithms to Biomarkers: Toward Personalized Management of Venous Thromboembolism. [PDF]

J Clin Med
Boccatonda A.
europepmc   +1 more source

Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy

, 2000
James D. Douketis, Gary Foster, Mark Crowther, Martin H. Prins, J S Ginsberg   +4 more
openalex   +1 more source

Family history and risk of venous thromboembolism with oral contraception [PDF]

, 2001
Jan P. Vandenbroucke, F.J.M. van der Meer, Frans M. Helmerhorst, Frits R. Rosendaal, Benilde Cosmi   +4 more
openalex   +1 more source

Comparative cardiovascular risk of sulfonylureas with low‐ and high‐affinities for cardiac mitochondrial adenosine triphosphate‐sensitive potassium channels versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: A cohort study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To individually evaluate the cardiovascular safety of low‐ and high‐affinity cardiac mitochondrial ATP‐sensitive potassium (mitoKATP) channel sulfonylureas by comparing each to dipeptidyl peptidase‐4 inhibitors (DPP‐4i), a generally cardiovascular‐neutral comparator, given prior evidence suggesting greater cardiovascular risk with high ...
Mei‐Hsiu Chen, Liang‐Yu Lin, Tung‐Ying Hung, Tzu‐Chieh Lin, Chia‐Yu Li, Tzu‐Han Lin, Yi‐Hsuan Chen, Jun‐Ting Liou, Meng‐Ting Wang   +8 more
wiley   +1 more source

The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation [PDF]

, 2001
Valerio De Stefano, Ida Martinelli, Pier Mannuccio Mannucci, Katia Paciaroni, Elena Rossi, Patrizia Chiusolo, Ida Casorelli, Giuseppe Leone   +7 more
openalex   +1 more source